An old one, belongs here just to document. Posted after the 80% decline, and before the buyout. Most classic worst timing of any investor I've ever followed.

A broken Mastino speaks! He claims he is done! You mean 8 years and an 80% loss is all it took?.

--------------------------------------------------------------------------

Dang. Almost bought some yesterday. Great news. Ya'll should be moving quite a bit today. Ill be on watch ;D

Premarket will open at 3.40 watch

I'm still a loser because I bought back in Dec. of 2014 for $3.58..but at least i recovered some of my losses.

SQNM is the third buyout I've been watching and/or been a part of this year. What a return today and I don't the final chapter's been written. After the dust settles it may yet be higher than 3x.

Man this stock really hit a home run today, go SQNM, what a return on this buyout.

Guess not

Today will be the 19th consecutive day with closing bid under $1, heading towards the 30 days after which NASDAQ starts the delisting procedure with a warning letter!

I am not trying to protect the company. In fact if you look up my posts you will see how negative I was about the operation and not trying to protect marty as we disagreed as well.

Many of the the conference calls were transcribed and are still found online. How about quoting guidance, and I mean guidance, not optimism, from any of those transcripts here? You cannot, because once again, this company has not provided guidance.

Oh, and btw, have you noticed the stock performance since the small "insider buying" which we were told meant the stock was heading higher?

All the conference calls had rosey projections. eom

Actually not. The company rarely if ever posted any guidance in the past 5 years. The lack of guidance would have shown a true talented analyst of the lack on confidence in SQNMs future, and should have told him there was a bumpy road ahead. Instead he chose to go with wishful fantasy, which resulted in an 80% loss.

The biggest problem trying to predict what the company would do was using the information & projections put out by company officers. They received very nice salaries and didn't want to upset the bank/bond investors and all projections were based on hope & change for the best. Marty took that info believed it all and stated his opinion, hopefully he has learned.
Harry Hixon got out awhile earlier, Bill Welch took over then left for Trovagene, most of the rats have left the ship with bags of money.

Not true. The removal from the Russell resulted in a 1 cent decline from the price 2 days before. Then, when the Supreme Court announced they were passing on the SQNM case, the plummet below $1 immediately started.

Removal from an index is advertised long in advance and market makers and arbitrage specialist set up in advance for the change, so that the actual day results in low volatility.

If a drop is needed before a recovery (I've never seen this discussed on any trading website before, so I'd like to hear where you have heard this from so I can research), perhaps we can drop to 50 cents, and then rise to 60 cents.

Bottom line, Sir Marty has been dead wrong on SQNM for over 5 years, and shows no sign of having a clue this year, just like any of the past 5!

The year ain't over. And stocks typically drop before they recover. The drop resulted from selling due to removal from Russell.

We are now down 45% this year since that amateur analyst, Marty Chilberg, who has been bullish since the $5 range, told us on his free analyst blog that 2016 was going to be a "turnaround year for SQNM".

He posted bullish articles at $4.50.
He posted bullish articles at $4.00.
He actually met with the CFO (waste of time for the poor exec) and then posted bullish articles at $3.00.
He posted bullish articles at $1.60.
And all the way down, even going down to $1, he boasted about buying more shares, and advised others to do so.

And so the "turnaround year for SQNM" that he foretold, at the midpoint, is down about 45%!

You get what you pay for with analysts sometimes!

Poor lawyers have to find another bird to pluck now.

SQNM's Supreme Court appeal has been denied!!!!

http://www.supremecourt.gov/orders/courtorders/062716zor_4fbi.pdf

Well, 4 years of hearing, "we'll win the court case and win damages", it is finally over!

Volume 1.3m more than doubled from the average 550k shares. Mutual funds/institutes finally leaving as most likley dead money. Cantor has a big position so expect they will keep it at a $1 to prevent delisting. If they dump and take their losses watch out. My guess is they want to put some lipstick on it and sell for what they can get later. Cutting expenses will be a priority, no more executive lunches, lol.

Under $1 now! This is the danger in giving credence to a wanna be perma bullish so called analyst who told us 2016 would be the "turnaround year for SQNM' (Marty Chilberg posted this on an amateur analyst site (google it)).

So far SQNM is down about 41% this year!

You did it again Marty!

At some point I suspect the article will mysteriously vanish, due to embarrassment!

There has been some insider activity so this could be a good time to accumulate some shares

Near all time lows again here!

If you ever want to know why amateur sites and advice should be ignored, take a look at the SQNM article posted on seekingalpha by Marty Chilberg, who has been bullish since the $5 range, and who is bullish yet again (anyone surprised?) telling us that 2016 was going to be a "turnaround year for SQNM" SQNM is down 36% so far this year!

Free "expert advice". You get what you pay for!

About to go bonkers

Thanks again smart money should be a fun day tomorrow

117M= http://finviz.com/quote.ashx?t=SQNM

Whats the float? Tia

$SQNM Announces Contracts w/ Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin

In a/h. Should be a nice pop tom

The new board (cantor fitzgerald) forces out Welch after he has destroyed the company. He was able to commit the company to a long term S Diego property lease because they love the area before being dumped. Of course they had to buy him out so he gets paid and now he goes over to Trovagene. Posard who know more leaves because he doesn't get the CEO job.

Agree with posters on yahoo board. With $130mil debt due by Sept 2017 & falling revenues, it is being viewed as ILMN's R&D shop at stockholder expense. Appears management is working collaboratively to run SQNM down. As some poster has quoted on yahoo, why would ILMN buy SQNM when they can steal it from willing insiders?
IMO, SQNM stockholders have been screwed by the SQNM board, a bunch of self serving crooks. I took my losses and exited at $1.70. So sorry for all the longs who have been destroyed.
Goodbye.

What do you think of things now, based on stock action. My guess is they ride it into the ground and get kicked out by the bondholders (unless they have sold and transferred the risk to retail).

Pendulum has overcorrected to the left.

Do not believe this management team is interested in getting bought out. They have too good. Free lunches, free stock options, bonuses for negative growth, etc. They do not care about shareholders, that's obvious.

However, time for correction has arrived. Estd annual revenue for 2015 of $130M x 2 (conservative factor)= $260M valuation = $2.20/share = reflects fair price today.

Near term drivers:
1. If SQNM EnBanc hearing is accepted, should correct to $3+ quickly
2. Any hint about revenue growth, which is expected in response to new contracts for high risk market (despite price competition), growth in pool revenue, growth in reimbursement for average risk market will be a positive. Expect revenue to correct to $160M for 2016. Price should correct to $160M x 2.5 = $400M = $3.40/share
3. Announcement of new partner to finance Liquid Biopsy development and market penetration will be a big boost in the near term.
4. Cash on hand is estimated to be at $70M at year end 2015. Announcement of tighter cash burn controls (not to exceed $24M in 2016) with profitability projection by end of 2016 will be a major credibility booster. It will prove they will end 2016 with >$45M on hand obviating the need to issue a secondary offering in the near future.

Look for sentiment to change after next conference call.

Thank you for the comments but not looking for any comparison to other posters. We each try our best and the debate was good without the flaming that happens on other boards. I am not that great of an analyst but some flags are easier to see. Heck check my hiphop stock and see how far under water I am on that one, lol. Sqnm Management was not dealing with reality and kept using projections not based on any real facts just hope. When I heard the executive club had lunch brought in every day so they could work yet none came in early or stayed late it sends a message. They actually came in late and left early to beat traffic. They spent money on buildings not needed, etc. They gave themselves nice stock grants along the way and changed the criteria to make bonus, it was all about them. Not sure where this ends up but expect the bond debt holders are all trying to figure a way out. They might short any significant stock rise to lessen the pain. I understand it is hard to find additional shares to short too many already being used.

Marty, I assume you understand now what stockmule meant when he/she told us of the pricing issues that SQNM was facing? People like stockmule see these things before they become obvious to the typical investor. That's what makes people like stockmule successful in investing.

ANYONE can say after today's announcement that pricing and competition are an issue, but stockmule, like a good analyst, saw it months ago!

FY15 Sales $127M-$131M vs $141M Est. - Sequenom Offers Q2 Sales Guidance. Just saw this elsewhere, I assume it is true.

That so called self declared "analyst" in SQNM just took it on the chin again! For YEARS he has been posting bullish "analysis" on SQNM never once saying this might be one to avoid! Well now it's less than half the price that is was during much of that time, and now, we have today's news and more decline to come!

When following amateur analysis you get amateur results. Makes sense, doesn't it?

CEO fired ops sorry resigned with the boards urging, lol. Now he has to buy his own lunch but gets a nice buyout to get rid of him. Problem is the interim is not going to fix things so expect them to continue to lose money.

FREEMONEY IN SQNM $2.02

I see we finally closed below $2 here! It was bound to happen soon!

I've read similar opinions, telling us that this ruling would be a blow to biotech. So, having read those opinions, similar to yours, I had a nice smile when the biotech index hit an all time high in the weeks following this latest ruling confirming that the patent is invalid.

To anyone who shares this uniformed view, once again, the market will make those with the wrong opinions pay, through losses! That is what capitalism is about. Rewarding those with correct opinions, while punishing those who just cannot grasp things. Investing can be mean, and SQNM investors are the first to know that... or.. they should, by now.

I have no desire to have a perpetual debate about the merits of the disallowal of 540. As I said before, this is a very disruptive ruling to innovation in bio land if not everywhere. If this isn't clear to you so be it. By the way, I've never thought that this patent would be upheld, only that the ramifications of it not being upheld are very significant to innovation in the US. I'll end my involvement with another reference to the appeal doc:

This is likely to lead to two negative—and ironic—results. First, it will encourage researchers to keep secret the very “basic tools of scientific and technological work” this doctrine is designed to render into a public good for the benefit of scientific progress. Mayo, 132 S. Ct. at 1293. Before the panel’s decision, those engaged in basic research could freely disclose their fundamental findings, secure in the
knowledge that—as Judge Bryson and the Supreme Court put it—they were in an excellent position to claim practical applications of that knowledge as the first parties to hold it. Now, the only way to protect a previously unknown and field-changing invention like the ’540 patent is to try to keep the fundamental discovery a secret as long as possible. That benefits no one, especially in fields like medicine where collaborative sharing of basic research is so fundamental to progress and the timely development of life-saving interventions.

Relatedly, this decision threatens the incentive to invest in this area at all. Researchers in the life sciences can now have no confidence of the patentability of their new methods for diagnosing and treating medical conditions; indeed, even if their patents could somehow survive the panel’s test, uncertainty will undermine investment at the outset. Moreover, trade secrets may be impossible to maintain in this area because of the regulatory approval process. Accordingly, those seeking new vaccines, new uses for existing drugs, new noninvasive tests, or other biomedical innovations will quite likely conclude that the game is no longer worth the candle. And who could blame them: They could revolutionize their field, teach their colleagues a method that is the diametric opposite of the conventional wisdom, create a practical test that confers enormous medical benefits on society, have their research cited close to a thousand times, and yet still be denied a patent because their previously unknown method relies on too fundamental a discovery they made about the natural world. Neither scientists
nor venture capitalists will see much to gain in basic biomedical\ research.

I was just reading on that site that allows armatures to post "analysis" a bullish view on SQNM! Kind of funny that it is down about 50% since that was posted! I noted all the "atta boy" comments posted to the review!

You get what you pay for as they say. "Free" analysis by amateurs can cost your more than you ever thought!

We are nearing $2 here.

People that don't fully understand the law, and don't understand the logical reason why the patent was thrown out, get taught by the market, through the price changes. $2! After all, investing is all about the stock price when it comes down to it!

Those that fully understand and grasp the issues at hand can understand where the stock is headed. Those that don't, don't.

Same as it ever was, here, there or any stock.

I will repeat again, with more detail, as apparently more clarity is needed

The judge, Susan Illston of the United States District Court in Northern California, issued a ruling on Wednesday that the patent was invalid because it covered a natural phenomenon — the presence of DNA from the fetus in the mother’s blood.

The ruling was a sign that the Supreme Court’s decision in June declaring that human genes may not be patented because they are products of nature could make it more difficult to patent diagnostic techniques.

Judge Illston cited the gene patent case, which involved Myriad Genetics, in her ruling, along with a 2012 Supreme Court decision invalidating patents on a test used to determine the proper dosages of certain drugs.

“It’s hard to imagine patents on diagnostics surviving if that approach is taken,” Christopher M. Holman, a law professor at the University of Missouri-Kansas City, said of Wednesday’s ruling.

A very logical and reasonable ruling!

Judge Linn wrote separately, explaining that he joined the result “only because [he was] bound by the sweeping language of the test set out in Mayo.” Linn Op. 1. In his view, “this case represents the consequence—perhaps unintended—of that broad language in excluding a meritorious invention from the patent protection it deserves and should have been entitled to retain.” Id. 2. Unlike the panel, he acknowledged Diehr, the Supreme Court’s endorsement of it in Mayo, and its applicability to this case. Id. 2-3. Nonetheless, he concluded that the language of Mayo, though unnecessary to the decision, seemed to compel a finding of ineligibility, id. 3—even while he made it emphatically clear that “Sequenom’s invention is nothing like the invention at issue in Mayo,” and there was “no reason, in policy or statute” to deny it eligibility. Id. 4-5

Nice to see this down now near 60% since May!

The market charges expensive prices for lessons to those that just cannot evaluate companies properly!

Critically, Lo and Wainscoat did not try to claim cffDNA itself or preempt any use of it by others. Id. To the contrary, peer-reviewed research has demonstrated practical uses for cffDNA that do not fractionate maternal blood, do not amplify the DNA, and do not detect paternally-inherited DNA. Id. 14.

Actually, they did, and that was the reason for the denial, and the failure on appeal.

"The judge, Susan Illston of the United States District Court in Northern California, issued a ruling on Wednesday that the patent was invalid because it covered a natural phenomenon — the presence of DNA from the fetus in the mother’s blood."

How can this be any more clear? How can there even be a discussion on whether or not this was the reason for the ruling?

They made no attempt to patent a natural phenomenum as they stated in teir patent. This appeal outlines the issue fairly well for anyone interested.

http://patentdocs.typepad.com/files/sequenom-petition.pdf

The courts decision was just and fair. The idea that the discovery of naturally occurring functions be patentable is ridiculous. Can you imagine someone patenting the discovery of blood types back when they were discoverd? Yep, that would be along the same lines!

Trading below $2.74 hitting $2.71. If it closes down watch out when the numbers come out it will get ugly. Not a stock I want to own and the options are too expensive right now.